Maestros Electronics Telecommun Systems Ltd vs Pramodini Medicare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Maestros Electronics & Telecommun. Systems Ltd is ₹ 77.7 as of 23 Oct 15:30 . The P/E Ratio of Maestros Electronics & Telecommun. Systems Ltd changed from 12.2 on March 2024 to 0 on March 2023 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Pramodini Medicare Ltd changed from 0 on March 2024 to 0 on March 2023 . This represents a CAGR of 0.0% over 5 years The Market Cap of Maestros Electronics & Telecommun. Systems Ltd changed from ₹ 60.31 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Pramodini Medicare Ltd changed from ₹ 0 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of 0.0% over 5 years The revenue of Maestros Electronics & Telecommun. Systems Ltd for the Jun '26 is ₹ 10.61 crore as compare to the Mar '26 revenue of ₹ 12.81 crore. This represent the decline of -17.17% The revenue of Pramodini Medicare Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Maestros Electronics & Telecommun. Systems Ltd for the Jun '26 is ₹ 2.4 crore as compare to the Mar '26 ebitda of ₹ 3.13 crore. This represent the decline of -23.32% The ebitda of Pramodini Medicare Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Maestros Electronics & Telecommun. Systems Ltd changed from ₹ 1.25 crore to ₹ 1.67 crore over 9 quarters. This represents a CAGR of 13.74% The net profit of Pramodini Medicare Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Maestros Electronics & Telecommun. Systems Ltd changed from 22.04 % on March 2022 to 0 % on March 2026 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Pramodini Medicare Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Maestros Electronics & Telecommun. Systems Ltd

Maestros Electronics & Telecommunications Systems Limited was incorporated on February 19, 2010.
At present, Company is engaged in activities pertaining to design, development, and manufacturing of creating products and services for financial inclusion, cardiology, gynecology, critical care patient and diseases management in medicine with rich experience in latest technologies and communication. It provide an advanced portfolio of products and services, including patient monitors, electrocardiographs, defibrillators, pulse oximeters, fetal monitors, stress test systems and much more. With state-of-the-art R&D and manufacturing facilities located in Mumbai, India, Company excel in creating cutting-edge solutions tailored to the needs of clients.
It mainly operates into two segments viz, Electronics & Instrumentation (E&T) and Telemedicine.

About Pramodini Medicare Ltd

Pramodini Medicare Limited was originally incorporated on September 12, 2000 as 'Pramodini Medicare Private Limited' with the Registrar of Companies, Andhra Pradesh.
Thereafter, the status of the Company changed to public limited Company and the name was changed to 'Pramodini Medicare Limited' vide fresh certificate of incorporation dated November 12, 2025. Company was originally incorporated in the year 2000 with the objective to provide diagnostic services.
The Company provide a range of technology-enabled diagnostic services such as radiology, clinical laboratory and nuclear medicine service to public hospitals, private hospitals, certain PSU (Public Sector Undertaking) of Government of India and medical colleges across tier I, tier II and tier III cities throughout India. Diagnostic services include a comprehensive range of offerings: (i) 'Radiology' which covers Magnetic Resonance Imaging (MRI), Computed Tomography (CT scan), X- ray, Ultrasound with colour doppler, Mammography, DEXA Scan and Intervention Radiology, (ii) 'Clinical Laboratory' which includes Haematology, Micro-Biology, Immunology, Pathology & Bio-Chemistry and (iii) 'Nuclear Medicine' which includes PET-CT (Positron Emission Tomography-Computed Tomography), SPECT (Single Photon Emission Computed Tomography) and Nuclear therapy.

FAQs for the comparison of Maestros Electronics & Telecommun. Systems Ltd and null

Which company has a larger market capitalization, Maestros Electronics & Telecommun. Systems Ltd or Pramodini Medicare Ltd?

Market cap of Maestros Electronics & Telecommun. Systems Ltd is 85 Cr while Market cap of Pramodini Medicare Ltd is 239 Cr

What are the key factors driving the stock performance of Maestros Electronics & Telecommun. Systems Ltd and Pramodini Medicare Ltd?

The stock performance of Maestros Electronics & Telecommun. Systems Ltd and Pramodini Medicare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Maestros Electronics & Telecommun. Systems Ltd and Pramodini Medicare Ltd?

As of October 25, 2026, the Maestros Electronics & Telecommun. Systems Ltd stock price is INR ₹77.7. On the other hand, Pramodini Medicare Ltd stock price is INR ₹108.65.

How do dividend payouts of Maestros Electronics & Telecommun. Systems Ltd and Pramodini Medicare Ltd compare?

To compare the dividend payouts of Maestros Electronics & Telecommun. Systems Ltd and Pramodini Medicare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.